Edwards Lifesciences Investments Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 118.03  2.46  2.13%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Investments of Edwards Lifesciences Corporation with missing and latest data points interpolated. A component of Total Assets representing the total amount of marketable and non-marketable securties, loans receivable and other invested assets.
Investments  10 Years Trend  
Increasing
Slightly volatile
 Investments 
      Timeline 

Edwards Lifesciences Investments Over Time

2015-12-31  886,200,000 
2016-12-31  873,100,000 
2017-12-31  925,947,368 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  419,078,947
Geometric Mean  193,336,355
Coefficient Of Variation  96.56
Mean Deviation  359,025,439
Median  301,100,000
Standard Deviation  404,680,568
Range  1,003,600,000
R Value  0.9
R Squared  0.8
Significance  0.00007587
Slope  100,701,472

Currently Trending

VMW   
 NYQ 
Purchased over 20 shares of
2 hours ago ago
Traded for 120.04
VMW   
 NYQ 
Purchased over 20 shares of
2 hours ago ago
Traded for 120.04
GOOG   
 NMS 
Purchased few shares of
2 hours ago ago
Traded for 1040.48